-+ 0.00%
-+ 0.00%
-+ 0.00%

Definitive Healthcare Q2 FY26 net loss narrows to $7.5 million; revenue drops 9% to $55.2 million

PUBT·08/10/2026 20:20:30
Listen to the news
Definitive Healthcare Q2 FY26 net loss narrows to $7.5 million; revenue drops 9% to $55.2 million
  • Definitive Healthcare Q2 revenue fell 9% year over year to USD 55.2 million; GAAP net loss narrowed to USD 7.5 million from USD 9.3 million.
  • Non-GAAP adjusted EBITDA slid to USD 14.6 million from USD 18.7 million; margin compressed 5 percentage points to 26%.
  • Operating cash flow was USD 11.5 million; non-GAAP unlevered free cash flow totaled USD 11.6 million.
  • Launched Turbo, an AI-powered healthcare intelligence platform; highlighted improving net dollar retention and win-back momentum, including a six-figure three-year enterprise return.
  • Guided Q3 revenue at USD 54-55 million; forecast full-year revenue of USD 220-222 million with non-GAAP adjusted EBITDA of USD 57-59 million.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Definitive Healthcare Corp. published the original content used to generate this news brief on August 10, 2026, and is solely responsible for the information contained therein.